This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Janet Rossant | |
|---|---|
| Name | Janet Rossant |
| Birth date | 1950 |
| Birth place | London |
| Nationality | British |
| Fields | Developmental biology, Stem cell research |
| Workplaces | Hospital for Sick Children, University of Toronto, Gairdner Foundation |
| Alma mater | University of Manchester, University of London |
| Known for | Pluripotent stem cell lineage tracing, mouse embryo analysis |
Janet Rossant Janet Rossant is a British-born developmental biologist and stem cell researcher whose work on mammalian embryo development and pluripotent stem cells has influenced developmental biology, stem cell research, regenerative medicine, genetics, and biotechnology. She has held leadership roles at the Hospital for Sick Children, the University of Toronto, and international science organizations such as the Gairdner Foundation and the International Society for Stem Cell Research. Her research integrates molecular genetics, lineage tracing, and embryology to elucidate cell fate decisions in mammalian development.
Rossant was born in London and educated in the United Kingdom, completing undergraduate and doctoral studies at the University of Manchester and University of London. During postgraduate training she worked with researchers in laboratories influenced by methodologies from Francis Crick, Sydney Brenner, John Gurdon, and contemporaries at institutions like the Medical Research Council and the National Institutes of Health. Early career fellowships and postdoctoral positions connected her to networks at the Wellcome Trust, Cambridge University, and the European Molecular Biology Laboratory.
Rossant's laboratory advanced techniques for lineage tracing in the mouse embryo, combining genetic reporters, gene-targeting strategies developed using concepts from Oliver Smithies and Martin Evans, and embryo culture methods paralleling work at the Institute of Cancer Research and Whitehead Institute. Contributions include identifying regulatory networks that govern trophoblast, epiblast, and primitive endoderm segregation, linking pathways such as FGF signaling, BMP signaling, Wnt signaling, and transcriptional regulators including Oct4, Sox2, Nanog, GATA6, and Cdx2. Her group provided evidence informing understanding of pluripotency states compared with findings from Shinya Yamanaka and studies of induced pluripotent stem cells at Kyoto University.
Rossant's work on extraembryonic lineages intersected with research from laboratories at the Max Planck Society, Harvard University, Stanford University, and Massachusetts Institute of Technology. She contributed to methodologies adopted by groups studying human embryo models at the Karolinska Institute, University of Cambridge, University of Oxford, and translational teams at Salk Institute and Riken. Collaborative projects integrated single-cell transcriptomics techniques akin to those developed at the Broad Institute and the Wellcome Sanger Institute, advancing cell atlas efforts coordinated with the Human Cell Atlas initiative. Her findings have influenced applied research in in vitro fertilization, congenital disease modeling, and approaches explored by pharmaceutical partners such as Pfizer and Novartis.
Rossant served as Chief of Research at the Hospital for Sick Children and held professorships at the University of Toronto while directing programs that connected academic, clinical, and funding bodies including the Canadian Institutes of Health Research, Canadian Foundation for Innovation, and provincial agencies. She chaired panels for the Gairdner Foundation, served on advisory boards for the European Research Council and the National Academy of Sciences, and participated in governance at the Royal Society and Royal Society of Canada. Her leadership engaged with policy forums such as meetings hosted by the World Health Organization and ethics discussions involving the International Society for Stem Cell Research and the Canadian Stem Cell Network.
Rossant's distinctions include recognition by the Royal Society, the Gairdner Foundation International Award, the Canada Gairdner Wightman Award, election to the Royal Society of Canada, and membership in the Order of Canada. She has received prizes such as the L'Oreal-UNESCO For Women in Science Award, the Canada Research Chairs Program honors, and awards from societies including the American Society for Cell Biology, the International Society for Stem Cell Research, Cold Spring Harbor Laboratory, and the Howard Hughes Medical Institute fellowship networks. Honorary degrees and fellowships have been conferred by the University of Cambridge, McGill University, Yale University, University College London, and the University of Edinburgh.
Rossant has balanced scientific leadership with engagement in public science communication and mentoring initiatives connected to organizations like the Royal Institution, Science Museum Group, and the Canadian Science Writers Association. She has collaborated with clinicians at Mount Sinai Hospital (Toronto), educators at the Ontario Institute for Studies in Education, and advocacy groups addressing research ethics at the Canadian Bioethics Society.
- Rossant J., lineage and fate mapping studies in mammalian embryos; papers published in journals such as Nature, Science, Cell, Development, and Nature Communications with coauthors from University of Toronto, Harvard Medical School, and Cambridge University. - Articles on pluripotency networks and extraembryonic lineages in Nature Genetics and Developmental Cell coauthored with investigators from Broad Institute and Wellcome Sanger Institute. - Reviews on embryonic patterning and stem cell models in Annual Review of Cell and Developmental Biology and commentaries in Nature Reviews Molecular Cell Biology.
Category:Developmental biologists Category:British biologists